ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Valbiotis SA

Valbiotis SA (ALVAL)

1.39
0.004
(0.29%)
終了 12月28日 1:30AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
1.39
買値
1.36
売値
1.398
出来高
72,235
1.34 日の範囲 1.39
1.07 52 週間の範囲 5.30
時価総額
前日終値
1.386
始値
1.342
時刻
1
@
1.39
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
77,163
発行済株式数
15,794,596
配当利回り
-
PER
-2.98
1 株当たり利益 (EPS)
-0.47
歳入
6.81M
純利益
-7.37M

Valbiotis SA について

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Paris, Paris, Fra
設立
-
Valbiotis SA is listed in the Pharmaceutical Preparations sector of the ユーロネクスト with ticker ALVAL. The last closing price for Valbiotis was 1.39 €. Over the last year, Valbiotis shares have traded in a share price range of 1.07 € to 5.30 €.

Valbiotis currently has 15,794,596 shares in issue. The market capitalisation of Valbiotis is 21.89 € million. Valbiotis has a price to earnings ratio (PE ratio) of -2.98.

ALVAL 最新ニュース

Valbiotis meldet durchschlagenden Erfolg der internationalen multizentrischen Phase-II/III-Studie REVERSE-IT zu TOTUM•63: nachgewiesene Wirksamkeit bei Hauptrisikofaktor für Typ-2-Diabetes

Die Studie erreichte ihr Ziel beim primären Endpunkt, der Senkung des Nüchternblutzuckers – Risikofaktor für Typ-2-Diabetes, bei einer Tagesdosis von 5 g und drei Verabreichungen pro Tag mit...

Valbiotis Announces the Large Success of the REVERSE-IT International Multicentric Phase II/III Clinical Study on TOTUM•63: Proven Efficacy on the Main Risk Factor of Developing Type 2 Diabetes

The study achieved its objective on the primary endpoint, the reduction of fasting blood glucose, a risk factor for type 2 diabetes, at a 5g daily dose in 3 intakes per day, with a high...

Valbiotis – Combined Annual Shareholders General Meeting held on May 2, 2023

Regulatory News: Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible), a commercially oriented Research and Development company, committed to scientific innovation for preventing and combating...

Valbiotis annonce la mise à disposition du Document d’Enregistrement Universel

Regulatory News: Valbiotis (FR0013254851 – ALVAL, éligible PEA / PME) (Paris:ALVAL), entreprise de Recherche et Développement à dimension commerciale, engagée dans l’innovation scientifique, pour...

Valbiotis annonce la tenue de son Assemblée générale mixte des actionnaires le 2 mai 2023

Regulatory News: Valbiotis (FR0013254851 – ALVAL, éligible PEA / PME) (Paris:ALVAL), entreprise de Recherche et Développement à dimension commerciale, engagée dans l’innovation scientifique, pour...

Valbiotis veröffentlicht seine Jahresergebnisse 2022 und gibt ein Update zu seiner strategischen Roadmap

Eine Barposition von mehr als 20 Millionen Euro zum Ende 2022, die dem Unternehmen finanzielle Visibilität bis zum Ende des ersten Halbjahres 2024 verschafft Ein entscheidendes Jahr an der...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.006-0.4297994269341.3961.3981.334412551.36064914DE
40.129.448818897641.271.521.2121089361.36957623DE
120.1613.00813008131.231.521.15771631.32394845DE
260.22619.41580756011.1641.91.08882031.42028891DE
52-3.27-70.17167381974.665.31.07811862.03293872DE
156-5.47-79.73760932946.867.51.07434543.24867393DE
260-0.77-35.64814814812.168.381.07343933.66889578DE

ALVAL - Frequently Asked Questions (FAQ)

What is the current Valbiotis share price?
The current share price of Valbiotis is 1.39 €
How many Valbiotis shares are in issue?
Valbiotis has 15,794,596 shares in issue
What is the market cap of Valbiotis?
The market capitalisation of Valbiotis is EUR 21.89M
What is the 1 year trading range for Valbiotis share price?
Valbiotis has traded in the range of 1.07 € to 5.30 € during the past year
What is the PE ratio of Valbiotis?
The price to earnings ratio of Valbiotis is -2.98
What is the cash to sales ratio of Valbiotis?
The cash to sales ratio of Valbiotis is 3.22
What is the reporting currency for Valbiotis?
Valbiotis reports financial results in EUR
What is the latest annual turnover for Valbiotis?
The latest annual turnover of Valbiotis is EUR 6.81M
What is the latest annual profit for Valbiotis?
The latest annual profit of Valbiotis is EUR -7.37M
What is the registered address of Valbiotis?
The registered address for Valbiotis is ZI DES QUATRE CHEVALIERS 12F RUE PAUL VATINE, PERIGNY, PARIS, PARIS, 17180
What is the Valbiotis website address?
The website address for Valbiotis is www.valbiotis.com
Which industry sector does Valbiotis operate in?
Valbiotis operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
ALEMSEuropean Medical Solutions
6.70 €
(37,122.22%)
40
CFNCofina SGPS SA
15.95 €
(2,146.48%)
2.17k
DMSBSDiagnostic Medical Systems
0.003 €
(50.00%)
52k
ALTROTronic s Microsystems
5.00 €
(48.81%)
8
SEQUASequana medical NV
3.87 €
(40.22%)
2.43M
EIFDSTour Eiffel DS
0.0184 €
(-57.41%)
110.23k
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
ALMEXMexedia SPA
5.00 €
(-23.08%)
40
ALEUPEuroplasma
0.0413 €
(-14.67%)
3.93M
MLFMVFarminveste
1.20 €
(-14.29%)
1.36k
ATOAtos SE
0.0027 €
(17.39%)
3.02B
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
NEOENNeoen SA
39.83 €
(0.73%)
81.42M
BCPBanco Comercial Portugues SA
0.4602 €
(2.04%)
75.06M
ALHPIHopium SA
0.005 €
(0.00%)
19.56M

最近閲覧した銘柄

Delayed Upgrade Clock